Shingles Vaccine Can Reduce Risk of Stroke And Heart Attack, Study Finds
Cardiovascular disease – involving the heart or blood vessels – is by far humanity's leading cause of death. It kills about 18 million people globally each year, mostly via heart attack or stroke.
While this is a daunting public health problem, medical science has revealed ways to lower risk: A heart-healthy diet helps, as do exercising daily, getting enough sleep, managing stress, and avoiding smoking.
According to the new study, covering data on more than 1.2 million people in South Korea over the age of 50, those who received a shingles vaccine showed a 23 percent lower risk of cardiovascular events overall.
This protection lasted for up to eight years, with the greatest reduction in risk observed two to three years after vaccination.
The effect was more pronounced in men, people younger than 60, and those with unhealthy behaviors such as smoking, drinking alcohol, or inactivity.
A shingles vaccination is already widely recommended for adults over 50 to protect against the viral disease, known for its painful skin rash and blisters.
Shingles is caused by the varicella-zoster virus – the culprit behind chickenpox. After people recover from chickenpox, typically in childhood, the virus can remain dormant in nerve cells for years or decades, then abruptly reactivate.
The immediate effects of shingles are bad enough, but while the rash usually fades in a few weeks, the disease can be insidiously persistent, explains pediatrician researcher Dong Keon Yon from Kyung Hee University in South Korea.
"Shingles causes a painful rash and can lead to serious complications, especially in older adults and those with weak immune systems," Yon says. "Research shows that, without vaccination, about 30 percent of people may develop shingles in their lifetime."
The most common complication is long-term nerve pain that can last for months or years. Shingles near the eyes can also lead to vision loss, and some people develop lasting neurological problems.
Recent research suggests shingles also raises stroke and heart attack risk. "In addition to the rash, shingles has been linked to a higher risk of heart problems, so we wanted to find out if getting vaccinated could lower this risk," Yon says.
The researchers merged data from several South Korean government agencies, ultimately studying more than 1.2 million people. Spanning 2012 to 2021, this included information on vaccination status as well as cardiovascular health and other relevant factors.
Vaccinated people had a 23 percent lower risk of cardiovascular events overall, including a 22 percent lower risk of coronary heart disease, a 26 percent lower risk of heart failure, and a 26 percent lower risk of a major cardiovascular event like stroke or heart attack.
"The shingles vaccine may help lower the risk of heart disease, even in people without known risk factors," Yon says.
That would be big news if confirmed, but makes sense given what we know about shingles' short-term effects on the cardiovascular system.
"A shingles infection can cause blood vessel damage, inflammation, and clot formation that can lead to heart disease," Yon explains. "By preventing shingles, vaccination may lower these risks."
One of the largest and most comprehensive of its kind, the study has some limitations, the authors acknowledge. The sample lacks diversity, since all subjects are from South Korea.
"While we conducted rigorous analysis, this study does not establish a direct causal relationship, so potential bias from other underlying factors should be considered," Yon says.
The study only addresses the live zoster vaccine, which uses a weakened form of the virus. There's also a recombinant subunit vaccine for shingles, featuring just a viral protein, that's increasingly prevalent in many countries.
In addition, previous research suggests both shingles vaccines may also protect against dementia.
The study was published in the European Heart Journal.
Spikes of Bird Flu in Cats Could Be a Warning of a Future Pandemic
HIV Drugs Dramatically Lower Risk of Alzheimer's Disease, Study Finds
Measles Could Become Endemic in US if Surge Continues, Expert Warns

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time Business News
25-07-2025
- Time Business News
Best Cleansers for Oily Skin in Pakistan: Affordable & Effective Picks for Daily Use
Everyone is tired of greasy skin. For people who love skincare, living in Pakistan's changing environment can cause multiple skin issues, especially dealing with excessive oil. But do not worry! We've found out the best cleansers for oily skin in Pakistan ranges that are especially tailored for oily skin. Say goodbye to that bad shine and welcome to a clean skin! Choosing the best cleanser for oily skin in Pakistan needs meticulous attention to elements like consistency, efficacy, and ingredients. The top five products mentioned below meet every requirement by offering an ideal balance of active ingredients and organic extracts for successfully treating oily skin issues. Let's find some affordable cleansers in Pakistan! OneSkin is an emerging skincare brand in Pakistan famous for clean, science-backed formulations. Their two standout cleansers for oily skin in Pakistan cater especially well to oily and combination skin. The Pore Purifying Gentle Gel Cleanser deeply cleanses pores and minimizes excess oil without drying the skin. On the other hand, the Hydra Cleanse Hydrating Foaming Cleanser gives a soft, hydrating cleanse which works best for sensitive, oily skin types. Regarded as the best cleansers for oily skin in Pakistan, they are perfect for daily use, leaving your skin fresh, balanced, and breathable. This brand's cleanser is the real winner for those with oily skin types, featuring a lot of excellent reviews. This cleanser is enriched with mild yet potent components like rice water and green tea that effectively clean the pores while ensuring vital hydration. Because of its gentle formulation, it leaves your skin feeling plump, clean and ready to flex the whole day. Anua is a South Korean company whose cleanser is selling hugely in Pakistan. Their cleanser constitutes organic elements like witch hazel and tea tree oil, significantly reducing the production of oil, pain and acne. With Anua's cleanser, outbreaks become a rare thing and smoother skin becomes the new normal. Christine offers multiple cleansers for people with oily skin. Their best-selling cleanser is Whitening Cleanser Tube which is enhanced with neem and lemon extracts, effectively cleansing pores of dirt, oil, and pollutants. This cleanser leaves your skin feeling fresh and radiant so you enjoy a pleasant experience. COSRX is a reputable brand in Pakistan that offers mild yet efficient skincare treatments. They bring multiple options of cleansers for people with oily skin types. However, their Salicylic Acid Gentle Daily Cleanser is highly loved by people. Enriched with salicylic acid and tea tree oil, it thoroughly gets rid of bacteria that cause acne and also scrubs dead skin cells and clears clogged pores. With COSRX, your skin can stay cleaner and oil-free. Incorporating a good cleanser in your daily skin care regimen is a must to getting a firm, clear appearance. With multiple options of cleansers for oily skin in Pakistan, it has become easy to get rid of oily debris and enjoy a clean smooth complexion. Our personal recommendation for the best cleanser for oily skin in Pakistan is OneSkin. Scientifically backed and loved by customers, your clear, fresh, and oil-free skin is just one step away! Head over to their website and shop now because such affordable cleansers in Pakistan are hard to find! Q1: What kind of cleanser is best for oily skin in Pakistan's climate? Gel-based or foaming cleansers are ideal, especially those offered by OneSkin. These help manage oil, prevent clogged pores, and reduce breakouts in humid weather. Q2: Can I use a cleanser for oily skin twice a day? Yes, cleansing in the morning and evening is recommended. Just ensure the formula is gentle and doesn't overly dry out your skin. Q3: Are local Pakistani brands effective for oily skin? Absolutely. Brands like OneSkin offer affordable and effective options using local-friendly ingredients like hyaluronic acid and tea tree oil that work well for oily and acne-prone skin. Q4: Can sensitive skin types use oily-skin cleansers? Yes, but opt for gentle formulations. Cleansers like OneSkin Hydra Cleanse are specifically made to cleanse your skin pores without damaging or irritating the skin barrier. Q5: Where can I buy these cleansers online in Pakistan? You can purchase them from skincare platforms and brand websites like OneSkin. Just look for your concern and get their amazing cleanser and that too, in an affordable price. Click here and read more blogs TIME BUSINESS NEWS

Miami Herald
21-07-2025
- Miami Herald
Korea's Hyundai ADM Bio developing new-concept cancer treatment
SEOUL July 21 (UPI) -- South Korea's Hyundai ADM Bio said Monday that the company is working on a new drug, Penetrium, intended to help enhance the efficiency of traditional cancer treatments. The firm said that its novel approach focuses on targeting the supportive structure around cancer cells, called the tumor microenvironment. or TME, which refers to the intricate network of elements that surrounds and sustain a tumor. "The interplay between cancer cells and their nearby components promotes tumor growth and invasion into healthy tissues, resulting in treatment resistance and poor clinical outcomes," Hyundai ADM Bio research head Kim Su-jong told a press conference in Seoul. "Penetrium acts on the TME by disrupting the cancer-friendly ecosystem, allowing conventional anticancer drugs to work more effectively and overcome resistance. It is an adjuvant for concurrent treatment," she said. In other words, she explained that Penetrium was a supplement for combination therapy with existing cancer drugs, rather than a substitute for them. Hyundai ADM Bio noted that it would start clinical study with Penetrium, which is based on niclosamide, a medication used to treat tapeworm infections South Korean authorities approved the first-phase clinical test in prostate cancer patients. For patients suffering from pancreatic and triple-negative breast cancers, the company plans to cooperate with its mother company, Hyundai Bioscience, to apply for clinical trials later this year at home and abroad. "Niclosamide is a tried-and-tested compound considered a promising candidate for treating various diseases. However, its low bioavailability has been a challenge. We aim to overcome it with our unique delivery system." Hyundai ADM Bio CEO designate Cho Won-dong said. "Preclinical results for Penetrium have shown encouraging outcomes. Clinical tests for patients with terminal-stage cancer will start first because they typically have very few therapeutic options left. In such cases, we could show the efficacy of Penetrium early on," he said. Cho was particularly hopeful that Penetrium would prove effective in preventing cancer metastasis. He plans to take charge of the company after a shareholder meeting July 31. Established in 2003, Hyundai ADM Bio went public on the Seoul bourse in 2021. It was acquired by the Korean biopharmaceutical company Hyundai Bioscience early last year. Copyright 2025 UPI News Corporation. All Rights Reserved.


UPI
21-07-2025
- UPI
Korea's Hyundai ADM Bio developing new-concept cancer treatment
Hyundai ADM Bio CEO designate Cho Won-dong speaks during a press conference in Seoul, Monday. Photo courtesy of Hyundai ADM Bio SEOUL July 21 (UPI) -- South Korea's Hyundai ADM Bio said Monday that the company is working on a new drug, Penetrium, intended to help enhance the efficiency of traditional cancer treatments. The firm said that its novel approach focuses on targeting the supportive structure around cancer cells, called the tumor microenvironment. or TME, which refers to the intricate network of elements that surrounds and sustain a tumor. "The interplay between cancer cells and their nearby components promotes tumor growth and invasion into healthy tissues, resulting in treatment resistance and poor clinical outcomes," Hyundai ADM Bio research head Kim Su-jong told a press conference in Seoul. "Penetrium acts on the TME by disrupting the cancer-friendly ecosystem, allowing conventional anticancer drugs to work more effectively and overcome resistance. It is an adjuvant for concurrent treatment," she said. In other words, she explained that Penetrium was a supplement for combination therapy with existing cancer drugs, rather than a substitute for them. Hyundai ADM Bio noted that it would start clinical study with Penetrium, which is based on niclosamide, a medication used to treat tapeworm infections South Korean authorities approved the first-phase clinical test in prostate cancer patients. For patients suffering from pancreatic and triple-negative breast cancers, the company plans to cooperate with its mother company, Hyundai Bioscience, to apply for clinical trials later this year at home and abroad. "Niclosamide is a tried-and-tested compound considered a promising candidate for treating various diseases. However, its low bioavailability has been a challenge. We aim to overcome it with our unique delivery system." Hyundai ADM Bio CEO designate Cho Won-dong said. "Preclinical results for Penetrium have shown encouraging outcomes. Clinical tests for patients with terminal-stage cancer will start first because they typically have very few therapeutic options left. In such cases, we could show the efficacy of Penetrium early on," he said. Cho was particularly hopeful that Penetrium would prove effective in preventing cancer metastasis. He plans to take charge of the company after a shareholder meeting July 31. Established in 2003, Hyundai ADM Bio went public on the Seoul bourse in 2021. It was acquired by the Korean biopharmaceutical company Hyundai Bioscience early last year.